| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.081 | 0.01 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.01 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.01 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |